The findings of this study indicate that clinicians should be attentive to the distributed variation of APOE ε4 alleles and their unfavorable effects on OCI with SCD complaints, but their additional contribution to SCD-Q9 scores is marginal in discriminating individuals with cognitive impairment from normal controls. The gene discussed is APOE; the disease is Schnyder corneal dystrophy.